Donafenib Combined with Camrelizumab and Transarterial Chemoembolization (TACE) As Conversion Therapy for Unresectable Hepatocellular Carcinoma (uhcc): A Prospective, Single-Arm, Phase II Study.
Journal of Clinical Oncology（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要